Malaria

GTS Steering Committee

The Steering Committee for the Global Technical Strategy consists of 14 members and three ex-officio members under the chairmanship of Professor Pedro Alonso, Director of the Barcelona Institute for Global Health (ISGlobal), Spain.

Group photo of the GTS Steering Committee Members (January 2014)
© Silvia Schwarte

Nomination of members

A nomination panel comprised of representatives from the WHO Global Malaria Programme (GMP) and the Malaria Policy Advisory Committee (MPAC) selected the Steering Committee members. They were nominated for their variety of experiences, technical expertise, competencies and skills to assist in the development of the Strategy. Special consideration was made for the following criteria:

  • Appropriate geographical representation from endemic countries;
  • Representation from different areas of technical expertise and experience with malaria and cross-cutting maternal child health issues; and
  • Gender balance.

Four Steering Committee members are also members of the Global Malaria Action Plan 2 (GMAP2) Task Force to ensure complementarity of these documents.

Members serve in an independent and personal capacity for a period of two years. Prior to being appointed, nominees were subject to a conflict of interest assessment by WHO, based on information that they disclosed on the WHO Declaration of Interest form, and were required to sign a WHO confidentiality agreement.

Key objectives and responsibilities of the Steering Committee

The Committee does not have a regulatory or an executive function. Its roles and responsibilities include, but are not limited to:

  • Providing guidance to the WHO Secretariat, under the direction of the MPAC, on the development of the Global Technical Strategy and reporting to the MPAC on progress;
  • Ensuring that the process to develop the Strategy is rigorous and inclusive of national and regional inputs and engages non-malaria specific stakeholders that work on maternal and child health issues; and
  • Coordinating the development of the Strategy with the Roll Back Malaria GMAP2 Task Force to ensure that the documents are complementary in scope.

Key document

Share